Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: Paul K who wrote (39)	12/30/1997 12:28:00 PM
From: WallStBum	Read Replies (1) \| Respond to of 288

CMED is poised well here IMO. Multiple recommendations, MCRR, Cohig, MH Meyerson, and now John G. Kinnard at a strong buy. This latest news is just an INITIAL order valued at $2.6 million increasing CMED's annual revenues approximately 10%. For 15 units = ~$175,000 per unit. For a machine that produces high-grade oxygen out of regular air - sounds sexy to me, anyways. I would like to see more "outside" sales. This contract is with Vencor a large owner of CMED stock, so while I'm excited for the contract, the thought at least crosses my mind as to whether they would get such a contract, but for the above connection. dax